PGP and neoplasm: For example, in the SipA-AuNP and doxorubicin combination treatment group, the potentiation effects of P-gp inhibition coupled with the chemotherapeutic drug were marked by profound decreases in both the tumour size and the number of cells, which enabled the SipA-AuNP to further penetrate the tumour and act on cells at an effective concentration.